AnaptysBio, Inc. (ANAB) Misses Q1 EPS by 5c

AnaptysBio, Inc. (NASDAQ: ANAB) reported Q1 EPS of ($1.64), $0.05 worse than the analyst estimate of ($1.59).

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Carvana (CVNA) PT Lowered to $85 at RBC Capital
• Nvidia pitches Vera CPU to Chinese clients with August delivery target